Related Experiment Video
Updated: May 20, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Histiocyte-rich rhabdomyoblastic tumor easily misdiagnosed as rhabdomyosarcoma: a case report
1Department of Pathology, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, Guizhou, People's Republic of China.
Background:
Histiocyte-rich rhabdomyoblastic tumor (HRRMT) is an extremely rare tumor of uncertain origin. Morphologically, it closely resembles inflammatory leiomyosarcoma (ILMS) without smooth muscle differentiation, making clinical diagnosis particularly challenging. Due to its rarity, HRRMT is often misdiagnosed as rhabdomyosarcoma, leading to unnecessary aggressive treatment.
Case Presentation:
A 62-year-old male was admitted to the hospital after an incidental discovery of a mass on his right thigh, first noticed seven days prior. Clinical examination revealed a well-circumscribed, painless mass measuring approximately 5 × 6 cm. Ultrasound and magnetic resonance imaging (MRI) suggested rhabdomyosarcoma in the distal sartorius muscle. However, histopathological analysis following surgical resection confirmed HRRMT. The patient did not undergo postoperative radiotherapy or chemotherapy, and no recurrence was observed during six months of follow-up.
Conclusions:
HRRMT is a rare tumor with favorable biological behavior. Given its morphological overlap with ILMS and rhabdomyosarcoma, early and accurate diagnosis is essential to prevent overtreatment. Extensive surgical resection remains an effective therapeutic approach. We report a case of HRRMT that is easily misdiagnosed as rhabdomyosarcoma, which will be a valuable case.
More Related Videos
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024